News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Penn Spinout Dispatch Bio Emerges from Stealth Mode with $216M in Funding
Dispatch Bio, co-founded by Carl June, MD, the Richard W. Vague Professor in Immunotherapy at Penn Medicine, is developing a universal cancer treatment for solid tumors.
Penn Spinout Interius Therapeutics To Be Acquired by Kite Therapeutics for $350M
Kite Therapeutics, a Gilead Company, has entered into a definitive agreement to acquire Interius Therapeutics .
Capstan Therapeutics Acquired by AbbVie for $2.1B
AbbVie acquired Capstan, including its lead asset CPTX2309.
September 2025 Bio/Medtech I-Corps Workshop
Penn I-Corps invites faculty, staff, postdocs, and students working on life science innovations to apply to the Special Bio/Medtech I-Corps Customer Discovery Workshop.
App that uses AI to boost caregiving for seniors wins PCI pitch competition at Philly Tech Week
PCI, Pennovation Works and Philadelphia Alliance for Capital & Technologies (PACT) hosted the “Innovate & Inspire: Research Panel & Pitch Competition” in May.
Penn Medicine’s David Fajgenbaum’s Story Inspiring a Hollywood Movie
Fajgenbaum discovered a treatment for Castleman Disease using an existing drug.
Penn Cell Therapy Pioneer Bruce Levine Co-Wrote Song with Country Artist Mags McCarthy Celebrating Cancer Treatment Breakthroughs
Levine co-wrote the inspirational song "Ring that Bell" with country artist Mags McCarthy.
Carl June Weighs in on FDA’s Cell and Gene Therapy Round Table
Carl June, MD, is the Richard W. Vague Professor in Immunotherapy at Penn Medicine .
PCI’s Managing Director Ben Dibling, PhD, Named a RealLIST Connector of 2025
The annual list features 20 individuals who collaborate with the tech community to foster inclusivity in Philadelphia
Penn Engineering’s Cherie Kagan Featured in Business Insider for Precision Agriculture Technology
Cherie Kagan, PhD, is the Stephen J. Angello Professor in Electrical and Systems Engineering in Penn Engineering.